Literature DB >> 8117717

Quantitation of the interaction of the immunosuppressant deoxyspergualin and analogs with Hsc70 and Hsp90.

K Nadeau1, S G Nadler, M Saulnier, M A Tepper, C T Walsh.   

Abstract

Deoxyspergualin (DSG), a spermidinyl, alpha-hydroxyglycyl, 7-guanidinoheptanoyl peptidomimetic, shows immunosuppressive activity. In confirmation of a recent report that immobilized methoxyDSG selectively retains the heat shock protein Hsc70, we report here quantitative binding of DSG and analogs to both Hsc70 and the 90-kDa heat shock protein Hsp90. We have utilized affinity capillary electrophoresis to obtain Kd values for DSG and analogs, and stimulation of the ATPase activity of Hsc70 to obtain Km values for DSG, that are comparable and corroborative. Kd values are 4 microM for DSG binding to Hsc70 and 5 microM for DSG binding to Hsp90. Two active analogs, methoxy- and glycylDSG, bind with similar affinities. Glyoxylylspermidine and des(aminopropyl)DSG, two inactive metabolites, have much reduced affinity for Hsc70 and Hsp90. These data validate binding of these novel immunosuppressant agents to these molecular chaperones, at concentrations in the range of pharmacologically active doses, and indicate that further characterization of Hsc70 and/or Hsp90 as potential targets for DSG is warranted.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8117717     DOI: 10.1021/bi00175a027

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

Review 1.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

2.  Cytosolic chaperones influence the fate of a toxin dislocated from the endoplasmic reticulum.

Authors:  Robert A Spooner; Philip J Hart; Jonathan P Cook; Paola Pietroni; Christian Rogon; Jörg Höhfeld; Lynne M Roberts; J Michael Lord
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

Review 3.  Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.

Authors:  Amanda K Davis; William B Pratt; Andrew P Lieberman; Yoichi Osawa
Journal:  Cell Mol Life Sci       Date:  2019-09-24       Impact factor: 9.261

Review 4.  Hsp70--a multi-gene, multi-structure, multi-function family with potential clinical applications.

Authors:  U Feige; B S Polla
Journal:  Experientia       Date:  1994-11-30

Review 5.  The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.

Authors:  Kristoffer R Brandvold; Richard I Morimoto
Journal:  J Mol Biol       Date:  2015-05-21       Impact factor: 5.469

6.  Design and synthesis of 15-deoxyspergualin-biotin conjugates as novel binding probes for target protein screening.

Authors:  Masahiko Morioka; Kuniki Kato; Kazuo Umezawa
Journal:  J Antibiot (Tokyo)       Date:  2016-03-23       Impact factor: 2.649

Review 7.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 8.  Heat-shock proteins: chaperoning DNA repair.

Authors:  Laurence Dubrez; Sébastien Causse; Natalia Borges Bonan; Baptiste Dumétier; Carmen Garrido
Journal:  Oncogene       Date:  2019-09-20       Impact factor: 9.867

9.  Pyrimidinone-peptoid hybrid molecules with distinct effects on molecular chaperone function and cell proliferation.

Authors:  Christine M Wright; Raj J Chovatiya; Nora E Jameson; David M Turner; Guangyu Zhu; Stefan Werner; Donna M Huryn; James M Pipas; Billy W Day; Peter Wipf; Jeffrey L Brodsky
Journal:  Bioorg Med Chem       Date:  2007-12-14       Impact factor: 3.641

Review 10.  Protein homeostasis as a therapeutic target for diseases of protein conformation.

Authors:  Barbara Calamini; Richard I Morimoto
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.